Today: 19 January 2026
Subscribe
Browse Category

Stock Market News 4 December 2025

Genuit Group PLC (LON: GEN) Stock: JPMorgan Lifts Target as M&G Buys 5% Stake After Profit Warning

Genuit Group PLC (LON: GEN) Stock: JPMorgan Lifts Target as M&G Buys 5% Stake After Profit Warning

Genuit Group PLC, the FTSE 250 provider of sustainable water, climate and ventilation products, is back in focus on 4 December 2025 after a busy few weeks of profit guidance cuts, a sharp share price sell‑off, fresh broker upgrades and a new major institutional shareholder. As of this morning, Genuit’s share price is trading around 330p, recovering from a 52‑week…
4 December 2025
···
UK Stock Market Today, 4 December 2025: FTSE 100 Slips as Utilities Drag but Mid‑Caps Jump on Earnings

UK Stock Market Today, 4 December 2025: FTSE 100 Slips as Utilities Drag but Mid‑Caps Jump on Earnings

London stocks traded broadly sideways on Thursday, 4 December 2025, with the FTSE 100 edging lower while mid‑caps and smaller companies outperformed on a busy day for corporate results. By mid‑morning, the blue‑chip index was down around 0.1% near 9,680–9,690, a touch below Wednesday’s close at 9,692 and still just shy of last month’s record high around 9,787. London South…
4 December 2025
···
Tokyo Stock Market Today, December 4, 2025: Nikkei 225 Leaps Above 51,000 as AI Rally and BOJ Rate Hike Bets Collide

Tokyo Stock Market Today, December 4, 2025: Nikkei 225 Leaps Above 51,000 as AI Rally and BOJ Rate Hike Bets Collide

Tokyo’s stock market delivered another powerful move higher on Thursday, December 4, 2025, as investors piled into artificial intelligence and robotics names even while long‑term interest rates in Japan hit their highest levels in nearly two decades and expectations for a Bank of Japan (BOJ) rate hike intensified. At the close, the Nikkei 225 jumped 1,163.74 points, or about 2.33%, to 51,028.42, while…
4 December 2025
···
Singapore Stock Market Today: STI Snaps Six-Day Rally, Slides 0.4% on US Slowdown Fears (4 December 2025)

Singapore Stock Market Today: STI Snaps Six-Day Rally, Slides 0.4% on US Slowdown Fears (4 December 2025)

Singapore’s stock market finally took a breather on Thursday, 4 December 2025, as the Straits Times Index (STI) slipped 0.4% to 4,535.14, ending a six-session winning streak that had pushed the benchmark to fresh highs. The Business Times Despite upbeat cues from Wall Street and firm expectations of a US Federal Reserve rate cut next week, local investors turned more…
4 December 2025
····
China Stock Market Today (December 4, 2025): Shanghai Edges Lower, Hong Kong Extends 2025 Rally as Investors Focus on 2026 Growth Target

China Stock Market Today (December 4, 2025): Shanghai Edges Lower, Hong Kong Extends 2025 Rally as Investors Focus on 2026 Growth Target

China’s stock markets delivered a quietly tense session on Thursday, December 4, 2025. Mainland benchmarks finished mixed and mostly flat, while Hong Kong’s Hang Seng Index continued its strong year-to-date run, even as weak economic data and a protracted property slump weighed on sentiment. Investors are increasingly trading every headline around Beijing’s expected 5% growth target for 2026, the trajectory…
4 December 2025
····
India Stock Market Today, December 4, 2025: Sensex, Nifty 50 Snap 4-Day Losing Streak as IT Stocks Rally and Rupee Breaches 90/USD

India Stock Market Today, December 4, 2025: Sensex, Nifty 50 Snap 4-Day Losing Streak as IT Stocks Rally and Rupee Breaches 90/USD

Indian equities ended a volatile Thursday session with modest gains, breaking a four-day losing streak even as the rupee hovered near record lows and foreign investors continued to pull money out of Dalal Street. IT stocks led the rebound, while mid- and small-caps and financials lagged, keeping overall sentiment cautious ahead of the Reserve Bank of India’s (RBI) crucial policy…
4 December 2025
··
Australia Stock Market Today: ASX 200 Climbs as Miners Rally and RBA Rate-Hike Bets Build – 4 December 2025

Australia Stock Market Today: ASX 200 Climbs as Miners Rally and RBA Rate-Hike Bets Build – 4 December 2025

The Australia stock market finished Thursday, 4 December 2025, modestly higher, with the S&P/ASX 200 once again leaning on heavyweight miners and materials stocks while traders priced in a higher chance of future Reserve Bank of Australia (RBA) rate hikes and a stronger Australian dollar. Market snapshot: ASX 200 edges higher on resource strength The S&P/ASX 200 closed around 8,618 points,…
4 December 2025
····
BP plc Stock on 4 December 2025: Near Record Highs, Buyback Blitz and a Hydrogen U‑Turn Drive the 2026 Story

BP plc Stock on 4 December 2025: Near Record Highs, Buyback Blitz and a Hydrogen U‑Turn Drive the 2026 Story

BP plc enters the final weeks of 2025 with its share price near record levels, an aggressive new share‑buyback tranche underway, and a controversial decision to scrap a flagship UK hydrogen project in favour of an AI data‑centre redevelopment. Together, these moves are reshaping how investors view BP’s balance between cash generation, fossil‑fuel growth and its longer‑term transition ambitions. Below…
4 December 2025
····
BAE Systems plc Stock Today (4 December 2025): Share Price Pullback, New Defence Contracts and 2026 Forecasts

BAE Systems plc Stock Today (4 December 2025): Share Price Pullback, New Defence Contracts and 2026 Forecasts

BAE Systems plc (LSE: BA., OTC: BAESY) remains one of the most closely watched defence stocks on the planet. As of 4 December 2025, the share price has cooled sharply from record highs, even as the company racks up fresh contracts in land systems, missiles, cyber and space, and reiterates upgraded guidance for 2025. Here’s a deep dive into where…
4 December 2025
····
London Stock Exchange Group (LSEG) Stock Today: OpenAI Deal, Board Changes and 2026 Forecasts – 4 December 2025

London Stock Exchange Group (LSEG) Stock Today: OpenAI Deal, Board Changes and 2026 Forecasts – 4 December 2025

London Stock Exchange Group plc (LON:LSEG) is having a busy start to December. On 4 December 2025, the owner of the London Stock Exchange and FTSE Russell is in the headlines for fresh board changes, new sustainability research, and ongoing AI partnerships – all against the backdrop of a share price that sits not far above its 52‑week low. Below…
4 December 2025
···
SSE PLC (LON:SSE) Stock on 4 December 2025: Ofgem Grid Ruling, Ex‑Dividend Drop and the £33bn Growth Plan

SSE PLC (LON:SSE) Stock on 4 December 2025: Ofgem Grid Ruling, Ex‑Dividend Drop and the £33bn Growth Plan

SSE PLC is back in the spotlight today – not because of a profit warning or a surprise deal, but because of the mundane but powerful forces that drive utility stocks: regulation, dividends and very large cheques for grid upgrades. On Thursday 4 December 2025, SSE shares traded around 2,175–2,180p, down a little over 2% in early London trade. The…
4 December 2025
····
NatWest Group Plc Stock Today: Buybacks, BoE Stress Test Win and 2026 Outlook as Shares Trade Near Highs

NatWest Group Plc Stock Today: Buybacks, BoE Stress Test Win and 2026 Outlook as Shares Trade Near Highs

NatWest Group Plc stock is trading close to its highest levels since the financial crisis as of 4 December 2025, powered by robust earnings, aggressive share buybacks and a clean bill of health from the Bank of England’s latest stress tests. TechStock² Where the NatWest share price stands on 4 December 2025 In London, NatWest’s LSE‑listed shares (LON: NWG) finished…
4 December 2025
····
1 … 1,033 1,034 1,035 1,036 1,037 … 1,465

Stock Market Today

  • Collegium Pharmaceutical (COLL) Valuation and Share Price Analysis Amid Recent Swings
    January 18, 2026, 10:26 PM EST. Collegium Pharmaceutical (NasdaqGS:COLL) saw a 31% gain over three months but dipped 7% in the past month, with its 1-year total shareholder return at 36.7%. Trading at $45.60, the stock appears undervalued compared to a fair value estimate of $53.17, boosted by margin expansion and earnings growth tied to products like Jornay PM. However, the price-to-earnings ratio of 24.7x surpasses industry and peer averages, signaling possible valuation risks if growth slows. Investors face uncertainties including generic competition and sales scaling of flagship products. Careful analysis is necessary to balance the upside potential against these risks in this specialty pharmaceutical player.
Go toTop